IUHSA
BIIB icon

Itau Unibanco Holding S.A.’s Biogen BIIB Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70
Closed -$1K – 341
2019
Q2 		$1K Buy
+70
New +$16.2K ﹤0.01% 630

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BIIB Position: Q2 2026 in Review

Itau Unibanco Holding S.A. reduced its Biogen (BIIB) stake by 0.29% in Q2 2026, selling an estimated $191 and leaving 348 shares worth $75.2K. The position accounts for ﹤0.01% of the portfolio, ranked #253.

Itau Unibanco Holding S.A. first reported a position in BIIB in Q3 2016 and has held it in 34 quarters since. The position peaked at $2.78M in Q3 2017. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Itau Unibanco Holding S.A. held 348 shares of Biogen worth $75.2K as of Q2 2026.
  • Itau Unibanco Holding S.A. sold 1 Biogen share in Q2 2026, an estimated $191.
  • Biogen made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #253 holding.
  • Itau Unibanco Holding S.A. first reported a position in Biogen in Q3 2016 and has held it in 34 quarters since.
  • Itau Unibanco Holding S.A.'s Biogen position peaked at $2.78M in Q3 2017.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.